Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dagmar Verweij"'
Autor:
Esther Drent, Sabine Middendorp, Andrea Bisso, Sjoerd Baardman, Dagmar Verweij, Estefania Salcedo, Chris Coomans, Steven Braem, Sander van de Weg, Menno Meijer, Natalie Proost, Marieke van de Ven, Haakan Norell, Marleen van Loenen, Nia Emami, Sara Melief, Stefania Gobessi, Mark Throsby
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Patricia H. J. van Cleef, Marian Stevens-Kroef, Iris D. Nagtegaal, Jeroen R. Dijkstra, Paul N. Span, Jolien Tol, Annet Simons, Susan Vermeulen, Peter Bult, Bastiaan B J Tops, Carlijn van de Water, Irene Otte-Höller, Dagmar Verweij, Margrethe Schlooz-Vries, Altuna Halilovic, Jeroen van der Laak, Janet Elsink, Oliver B. A. Boelens
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
Scientific Reports, 9
Scientific Reports
Scientific Reports, 9
Breast cancer treatment depends on human epidermal growth factor receptor-2 (HER2) status, which is often determined using dual probe fluorescence in situ hybridisation (FISH). Hereby, also loss and gain of the centromere of chromosome 17 (CEP17) can
Autor:
Esther Drent, Andrea Bisso, Sjoerd Baardman, Dagmar Verweij, Estefania Salcedo, Chris Coomans, Steven Braem, Sander van de Weg, Sara Melief, Haakan Norell, Marleen van Loenen, Stefania Gobessi, Mark Throsby
Publikováno v:
Cancer Research. 82:2818-2818
Broad application of cell therapies like CAR-T have been hampered by a lack of tumor-specific targets. Gadeta leverages the natural HLA-independent tumor recognition capabilities of γδTCRs combined with the proliferative capacity and robust tumor k
Autor:
Cornelis J. A. Punt, Han van Krieken, Willeke A. M. Blokx, Patricia J. T. A. Groenen, Carl G. Figdor, I. Jolanda M. de Vries, Johannes Textor, Kalijn F. Bol, Angela Vasaturo, Altuna Halilovic, Dagmar Verweij
Publikováno v:
Cancer Research, 76, 12, pp. 3496-506
Cancer Research, 76, 3496-506
Cancer research, 76(12), 3496-3506. American Association for Cancer Research Inc.
Cancer Research, 76, 3496-506
Cancer research, 76(12), 3496-3506. American Association for Cancer Research Inc.
Contains fulltext : 171597.pdf (Publisher’s version ) (Open Access) Tumor-infiltrating lymphocytes appear to be a predictor of survival in many cancers, including cutaneous melanoma. We applied automated multispectral imaging to determine whether d
Autor:
I. Jolanda M. de Vries, Johannes Textor, Dagmar Verweij, Iresha N. Wickramasinghe, Altuna Halilovic, Carl G. Figdor, Mark A.J. Gorris, Inge M. N. Wortel, Anne van Duffelen, Katrin Rabold
Publikováno v:
Journal of Immunology, 200, 1, pp. 347-354
Journal of Immunology, 200, 347-354
Journal of Immunology, 200, 347-354
Contains fulltext : 190315.pdf (Publisher’s version ) (Open Access) Therapies targeting immune checkpoint molecules CTLA-4 and PD-1/PD-L1 have advanced the field of cancer immunotherapy. New mAbs targeting different immune checkpoint molecules, suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5939c2e440e6c8c6bc6ca8c83ff3f8
https://doi.org/10.4049/jimmunol.1701262
https://doi.org/10.4049/jimmunol.1701262
Autor:
Akira Asai, I. Jolanda M. de Vries, Dagmar Verweij, Gerrit K. J. Hooijer, Hanneke W. M. van Laarhoven, Johan H. J. M. van Krieken, Anja E. Pen, Stanleyson V. Hato, Susumu Takahashi, W. Joost Lesterhuis, Kalijn F. Bol, Nienke de Haas, Yukie Inoue, Angela Vasaturo, Altuna Halilovic, Johannes H.A.M. Kaanders, Carla M.L. van Herpen, Cornelis J. A. Punt, Carl G. Figdor
Publikováno v:
Oncotarget, 8, 33, pp. 54434-54443
Oncotarget
Oncotarget, 8(33), 54434-54443. Impact Journals
Oncotarget, 8, 54434-54443
Oncotarget
Oncotarget, 8(33), 54434-54443. Impact Journals
Oncotarget, 8, 54434-54443
// Stanleyson V. Hato 1 , Carl G. Figdor 1 , Susumu Takahashi 5 , Anja E. Pen 1 , Altuna Halilovic 2 , Kalijn F. Bol 1, 3 , Angela Vasaturo 1 , Yukie Inoue 5 , Nienke de Haas 1 , Dagmar Verweij 2 , Carla M.L. Van Herpen 3 , Johannes H. Kaanders 4 , J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ce4bf577dba4aba5bbd43a9108bae6
https://doi.org/10.18632/oncotarget.17661
https://doi.org/10.18632/oncotarget.17661
Autor:
Willeke A. M. Blokx, Stefania Di Blasio, I. Jolanda M. de Vries, J. Han van Krieken, Carl G. Figdor, Dagmar Verweij, Angela Vasaturo
Publikováno v:
Histopathology, 70, 4, pp. 643-649
Histopathology, 70, 643-649
Histopathology, 70(4), 643. Wiley-Blackwell
Histopathology, 70, 643-649
Histopathology, 70(4), 643. Wiley-Blackwell
Contains fulltext : 173035.pdf (Publisher’s version ) (Open Access) AIMS: The quality and quantity of the infiltration of immune cells into tumour tissues have substantial impacts on patients' clinical outcomes, and are associated with response to
Autor:
Carl G. Figdor, Jolanda De Vries, Han van Krieken, Patricia J. T. A. Groenen, Willeke A. M. Blokx, Kalijn F. Bol, Johannes Textor, Angela Vasaturo, Altuna Halilovic, Dagmar Verweij
Publikováno v:
Journal for Immunotherapy of Cancer
Melanoma is a highly malignant melanocyte-derived tumor and its incidence is increasing at outstanding rate. Despite different types of immunotherapy became available for the treatment of melanoma, including adoptive T cell transfer, immune checkpoin
Autor:
Willeke A. M. Blokx, Jolanda De Vries, Dagmar Verweij, Angela Vasaturo, Altuna Halilovic, Kalijn F. Bol, Johannes Textor, Han van Krieken, Patricia J. T. A. Groenen, Carl G. Figdor
Publikováno v:
Cancer Immunology Research. 4:A016-A016
Melanoma is a highly malignant melanocyte-derived tumor and its incidence is increasing at outstanding rate. Despite different types of immunotherapy became available for the treatment of melanoma, including adoptive T cell transfer, immune checkpoin
Autor:
Willeke A. M. Blokx, Carl G. Figdor, Jolanda De Vries, Angela Vasaturo, Lucie Heinzerling, Dagmar Verweij
Publikováno v:
Journal of Translational Medicine, 13, 2080
Europe PubMed Central
Journal of Translational Medicine, 13, pp. 2080
Journal of Translational Medicine
Europe PubMed Central
Journal of Translational Medicine, 13, pp. 2080
Journal of Translational Medicine
Background Melanoma is a highly malignant melanocyte-derived tumor and its incidence is increasing at outstanding rate. Despite specific therapies have been explored for many years, no effective therapeutic options have been developed. Vaccination st